Top Cancer Registry Software Companies

Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 and is poised to grow from USD 78.09 Million in 2024 to USD 191.81 Million by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

The global cancer registry software market is highly competitive and therefore dominated by major players who influence innovation in the market as well as its growth. Some of the key international companies include IBM Watson Health, Oracle Corporation and Siemens Healthineers that are engaged in data management, analytics and integration solutions. They use advanced technologies to improve cancer registries, increase the accuracy of information and facilitate clinical research making them stand out among others in this fast-changing marketplace. 'IBM Watson Health ', 'Oracle Corporation ', 'Siemens Healthineers ', 'Cerner Corporation ', 'Epic Systems Corporation ', 'MEDITECH ', 'Allscripts Healthcare Solutions ', 'McKesson Corporation ', 'Philips Healthcare ', 'GE Healthcare ', 'Inova Health System ', 'Varian Medical Systems ', 'Roche Diagnostics ', 'TomoTherapy Inc. ', 'Health Information Systems ', 'Elekta ', 'ONCO, Inc. ', 'Conduent, Inc. ', 'Ordinate Corporation ', 'Volpara Health Limited'

Building cancer registries are being aided by activities from several government agencies to reduce cancer incidence. Government organizations everywhere are attempting to digitize and integrate healthcare systems, including the creation of computerized illness registries, in response to the growing demand for population health management and the interchange of health information.

Comprehensive Data Management and Global Adoption: Notable trends in the global cancer registry software market reflect the changing face of oncology care and the growing emphasis on comprehensive management of cancer data. An acute tendency in the world is the growth in the utilization of cancer registry software systems by hospitals. These software systems are significant for efficiently collecting, processing and arranging patient information regarding cancer.

The global cancer registry software market is primarily dominated by North America due to its advanced healthcare infrastructure, significant amounts spent on medical research, and strict regulatory regimes. Moreover, the region enjoys high adoption of sophisticated technologies and an extensive network of cancer research institutions and healthcare providers. Furthermore, cancer treatment and database management projects driven by governments together with their funding tend to accelerate the pace of the market. The leadership in this segment is attributed to significant participants in the industry and continuous advancement of software applications meant for use in healthcare systems within North America.